RWJ-58436

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameRWJ-58436

Drug Alias NameRWJ-58436

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine protease inhibitors

TargetsSerine protease

Therapy Area/IndicationsThrombosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesJohnson & Johnson

Active IndicationsN/A

Inactive IndicationsThrombosis

ATC CodeN/A